Physician profile
David Farrell Armstrong
NPI 1134353964
$947.64
in general payments reported to CMS, 2019-2025
15 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $31.28 · 2021: $134 · 2022: $133 · 2023: $73.30 · 2024: $264 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $285.12 | 2020-2025 | |
| Abbvie INC. | $90.13 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $87.46 | 2019 | |
| Pfizer INC. | $77.35 | 2022-2024 | |
| Irhythm Technologies, INC. | $62.77 | 2024 | Zio Monitor, Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.06 | 2021-2023 | Lifevest |
| Baxter Healthcare | $49.51 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $41.82 | 2019-2021 | |
| Abbott Laboratories | $37.73 | 2023-2025 | Mitraclip, Aveir |
| Janssen Pharmaceuticals, INC | $33.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.88 | 2021-2023 | Eliquis |
| Inari Medical, INC. | $29.50 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $25.56 | 2025 | Bodyguardian |
| Philips North America LLC | $22.79 | 2025 | Extended Holter |
| Kiniksa Pharmaceuticals International, Plc | $17.96 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.